Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Cumulative Translation Adjustments
Beginning balance (in shares) at Dec. 31, 2021			68,126
Beginning balance at Dec. 31, 2021	$ 31,727	$ 0	$ 68	$ 200,614	$ (168,953)		$ (2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock (in shares)	29
Issuance of restricted stock	$ 0
Share-based compensation	3,184			3,184
Translation adjustment	4						4
Net loss	(14,137)				(14,137)
Ending balance (in shares) at Jun. 30, 2022			68,155
Ending balance at Jun. 30, 2022	$ 20,778		$ 68	203,798	(183,090)		2
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-13 [Member]
Beginning balance (in shares) at Dec. 31, 2021			68,126
Beginning balance at Dec. 31, 2021	$ 31,727	0	$ 68	200,614	(168,953)		(2)
Ending balance (in shares) at Dec. 31, 2022			74,567
Ending balance at Dec. 31, 2022	28,672	(29)	$ 74	214,094	(185,493)	$ (29)	(3)
Beginning balance (in shares) at Mar. 31, 2022			68,149
Beginning balance at Mar. 31, 2022	25,877		$ 68	202,502	(176,693)		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock (in shares)			6
Issuance of restricted stock	0
Share-based compensation	1,296			1,296
Translation adjustment	2						2
Net loss	(6,397)				(6,397)
Ending balance (in shares) at Jun. 30, 2022			68,155
Ending balance at Jun. 30, 2022	20,778		$ 68	203,798	(183,090)		2
Beginning balance (in shares) at Dec. 31, 2022			74,567
Beginning balance at Dec. 31, 2022	28,672	$ (29)	$ 74	214,094	(185,493)	$ (29)	(3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock (in shares)			289
Issuance of restricted stock	1		$ 1
Share-based compensation	2,597			2,597
Translation adjustment	2						2
Net loss	(4,093)				(4,093)
Ending balance (in shares) at Jun. 30, 2023			74,856
Ending balance at Jun. 30, 2023	27,150		$ 75	216,691	(189,615)		(1)
Beginning balance (in shares) at Mar. 31, 2023			74,666
Beginning balance at Mar. 31, 2023	28,017		$ 74	215,367	(187,424)		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock (in shares)			190
Issuance of restricted stock	1		$ 1
Share-based compensation	1,324			1,324
Translation adjustment	(1)						(1)
Net loss	(2,191)				(2,191)
Ending balance (in shares) at Jun. 30, 2023			74,856
Ending balance at Jun. 30, 2023	$ 27,150		$ 75	$ 216,691	$ (189,615)		$ (1)